Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anweitai
- Development stage
- Unknown
- Lead developer
- Livzon Pharmaceutical
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous
01
Overview
Anweitai (安维泰) is a recombinant humanized monoclonal antibody biosimilar of tocilizumab, developed and marketed by Livzon Pharmaceutical Factory. It targets the interleukin-6 receptor (IL-6R), binding to both its soluble and membrane-bound forms to inhibit IL-6-mediated pro-inflammatory signaling. This blockade prevents the activation of downstream pathways involved in the pathogenesis of various inflammatory and autoimmune conditions. Anweitai is approved in China for the treatment of rheumatoid arthritis, cytokine release syndrome (CRS), and systemic juvenile idiopathic arthritis (sJIA). It is formulated as an injection for intravenous or subcutaneous administration.
- Brand names
- 安维泰Anweitai
- Other names
- 托珠单抗注射液Tocilizumab Injection
02
Targets
IL-6R (Interleukin-6 receptor subunit alpha)
Beyond the preview
Go deeper on Anweitai.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anweitai.